These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 5780035)
1. The use of methotrexate in the treatment of uveitis. Giles CL Univ Mich Med Cent J; 1969; 35(1):30-1. PubMed ID: 5780035 [No Abstract] [Full Text] [Related]
2. Methotrexate treatment of uveal disease. Wong VG Am J Med Sci; 1966 Feb; 251(2):239-41. PubMed ID: 5904740 [No Abstract] [Full Text] [Related]
3. [Aspects of treatment with immunosuppressive agents in ophthalmology]. Micşa MV; Weinberg J; Ciocan I; Zapolschi D; Popovici S Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1981; 25(3):233-5. PubMed ID: 6460300 [No Abstract] [Full Text] [Related]
4. [Corticosteroids in ophthalmology]. Trzcińska-Dabrowska Z Pol Tyg Lek; 1972 Jun; 27(26):1008-10. PubMed ID: 4560602 [No Abstract] [Full Text] [Related]
5. Treatment of uveitis with methotrexate. Lazar M; Weiner MJ; Leopold IH Am J Ophthalmol; 1969 Mar; 67(3):383-7. PubMed ID: 4304465 [No Abstract] [Full Text] [Related]
6. Development of sympathetic uveitis in spite of corticosteroid therapy. Kay ML; Yanoff M; Katowitz JA Am J Ophthalmol; 1974 Jul; 78(1):90-4. PubMed ID: 4835058 [No Abstract] [Full Text] [Related]
7. [Failures of cytostatic treatment in ophthalmology (author's transl)]. Martenet AC Klin Monbl Augenheilkd; 1980 Apr; 176(4):648-51. PubMed ID: 7421049 [TBL] [Abstract][Full Text] [Related]
11. The safety of intraocular methotrexate in silicone-filled eyes. Hardwig PW; Pulido JS; Bakri SJ Retina; 2008 Oct; 28(8):1082-6. PubMed ID: 18779714 [TBL] [Abstract][Full Text] [Related]
12. [Use of the protease inhibitor kontrikal in treating phakogenic uveitis]. Kot OA; Moskovchenko KP; Protsenko VA Oftalmol Zh; 1984; (8):486-9. PubMed ID: 6085150 [No Abstract] [Full Text] [Related]
13. Multimodality diagnostic imaging in a case of sympathetic ophthalmia. Fleischman D; Say EA; Wright JD; Landers MB Ocul Immunol Inflamm; 2012 Aug; 20(4):300-2. PubMed ID: 22594960 [No Abstract] [Full Text] [Related]
14. [Significance of external exposure of the uvea in the development of sympathetic ophthalmia and indication for exenteration of the involved eye]. Ikui H Nihon Ganka Kiyo; 1970 Sep; 21(9):659-60. PubMed ID: 5529298 [No Abstract] [Full Text] [Related]
15. Treatment of a presumed case of sympathetic ophthalmia with methotrexate. Wong VG; Hersh EM; McMaster PR Arch Ophthalmol; 1966 Jul; 76(1):66-76. PubMed ID: 5943678 [No Abstract] [Full Text] [Related]
16. [Sympathetic ophthalmia and immunodepressive treatment]. de Marigny G; Mouillon M Bull Soc Ophtalmol Fr; 1971 Dec; 71(12):1114-6. PubMed ID: 5154062 [No Abstract] [Full Text] [Related]
17. [A case of sympathetic uveitis in a patient with an immunologic disorder]. Smoleńska-Janicowa D; Bernacka K Klin Oczna; 1983 Jul; 85(7):285-6. PubMed ID: 6645299 [No Abstract] [Full Text] [Related]
18. Methotrexate and chronic uveitis associated with juvenile idiopathic arthritis. Chan AY; Liu DT J Rheumatol; 2006 Jan; 33(1):198; author reply 198. PubMed ID: 16395772 [No Abstract] [Full Text] [Related]
19. THE UVEA. KAUFMAN HE Arch Ophthalmol; 1965 Mar; 73():420-9. PubMed ID: 14246199 [No Abstract] [Full Text] [Related]
20. Sympathetic ophthalmia. A re-evaluation of management. Tarr KH; Billson FA Trans Ophthalmol Soc N Z; 1982; 34():70-3. PubMed ID: 6953698 [No Abstract] [Full Text] [Related] [Next] [New Search]